112 related articles for article (PubMed ID: 8724426)
1. Central opiate modulation of growth hormone and insulin-like growth factor-I.
Hashiguchi Y; Molina PE; Fan J; Lang CH; Abumrad NN
Brain Res Bull; 1996; 40(2):99-104. PubMed ID: 8724426
[TBL] [Abstract][Full Text] [Related]
2. Central effects of morphine and morphine-6-glucuronide on tissue protein synthesis.
Hashiguchi Y; Molina PE; Preedy VR; Sugden PH; McNurlan MA; Garlick PJ; Abumrad NN
Am J Physiol; 1996 Sep; 271(3 Pt 2):R619-25. PubMed ID: 8853383
[TBL] [Abstract][Full Text] [Related]
3. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854
[TBL] [Abstract][Full Text] [Related]
4. Morphine-3-glucuronide: hyperglycemic and neuroendocrine potentiating effects.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res; 1995 Oct; 694(1-2):13-20. PubMed ID: 8974636
[TBL] [Abstract][Full Text] [Related]
5. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronide.
Molina PE; Hashiguchi Y; Ajmal M; Mazza M; Abumrad NN
Brain Res; 1994 Nov; 664(1-2):126-32. PubMed ID: 7895021
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of brain, liver, and muscle glycogen to opiates and surgical stress.
Hashiguchi Y; Molina PE; Boxer R; Naukam R; Abumrad NN
Surg Today; 1998; 28(4):471-4. PubMed ID: 9590724
[TBL] [Abstract][Full Text] [Related]
7. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin.
Fan J; Molina PE; Gelato MC; Lang CH
Endocrinology; 1994 Apr; 134(4):1685-92. PubMed ID: 7511091
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the insulin-like growth factor system by acute acidosis.
Bereket A; Wilson TA; Kolasa AJ; Fan J; Lang CH
Endocrinology; 1996 Jun; 137(6):2238-45. PubMed ID: 8641171
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I and growth hormone administration in intestinal ischemia shock in the rat.
Haglind E; Malmlof K; Fan J; Lang CH
Shock; 1998 Jul; 10(1):62-8. PubMed ID: 9688093
[TBL] [Abstract][Full Text] [Related]
10. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis.
Soto L; Martín AI; Millán S; Vara E; López-Calderón A
J Endocrinol; 1998 Nov; 159(2):239-46. PubMed ID: 9795364
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I.
Lemmey AB; Glassford J; Flick-Smith HC; Holly JM; Pell JM
J Endocrinol; 1997 Aug; 154(2):319-28. PubMed ID: 9291843
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion.
Harel Z; Tannenbaum GS
Endocrinology; 1992 Aug; 131(2):758-64. PubMed ID: 1639021
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of growth hormone in alcohol-fed rats.
Lang CH; Liu X; Nystrom G; Wu D; Cooney RN; Frost RA
Alcohol Alcohol; 2000; 35(2):148-58. PubMed ID: 10787390
[TBL] [Abstract][Full Text] [Related]
16. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.
Ramos S; Goya L; Alvarez C; Martín MA; Pascual-Leone AM
J Endocrinol; 2001 Apr; 169(1):111-22. PubMed ID: 11250652
[TBL] [Abstract][Full Text] [Related]
17. Centrally administered insulin-like growth factor II fails to alter pulsatile growth hormone secretion or food intake.
Harel Z; Tannenbaum GS
Neuroendocrinology; 1992 Aug; 56(2):161-8. PubMed ID: 1407369
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
[TBL] [Abstract][Full Text] [Related]
19. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.
Lang CH; Vary TC; Frost RA
Endocrinology; 2003 Sep; 144(9):3922-33. PubMed ID: 12933666
[TBL] [Abstract][Full Text] [Related]
20. Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.
Dunaiski V; Dunshea FR; Walton PE; Goddard C
J Endocrinol; 1997 Dec; 155(3):559-65. PubMed ID: 9488001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
